Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 66

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 66
---
                                          |     | Attract and retain talented executives and provide stable source of income                                                                        |
| Short-Term Incentives —Annual Bonus Plan Awards |     | At risk, performance-based annual cash incentive opportunity                                                                                                 
 •Funding of single company Applicable Distribution Percentage based on Company performance against three key financial metrics and ESG and Quality Modifiers 
 •Actual payout based on individual performance                                                                                                               |     | Align executive compensation with our business strategy, quality, and profitability objectives                                                    
 Focus and reward based on the achievement of important financial, operational, environmental, human capital and individual performance objectives |
| Long-Term Incentives —Equity Awards             |     | At risk, performance-based equity incentive opportunity                                                                                                      
 Mix of opportunity composed of:                                                                                                                              
 •25% target ONSG performance-based RSUs                                                                                                                      
 •25% target rTSR performance-based RSUs                                                                                                                      
 •25% stock options                                                                                                                                           
 •25% service-based RSUs                                                                                                                                      |     | Focus talent/organization on important financial measures and long-term stockholder value                                                         
 Reward based on:                                                                                                                                  
 •our ONSG measured against our financial plan performance for organic net sales                                                                   
 •our TSR relative to that of other S&P 500 Health Care Index companies                                                                            
 •our stock price and any subsequent increase                                                                                                      |

#### Base Salary
In determining the 2024 base salaries of our NEOs (other than our CEO), our Compensation Committee also considered the recommendations of our CEO in light of the general factors discussed above, including each of their overall performance ratings for the prior year. The salary increases in 2024 were in recognition of individual performance and to bring in line with compensation levels for similarly situated executives within the Company’s peer group.

#### 562025 Proxy Statement

### Compensation Discussion & Analysis
The 2024 base salaries (rounded to the nearest thousand) for our NEOs, as well as the percentage increase from their 2023 base salaries, are set forth below:

| Name                 |     | 2023 Base Salary |     |   |           |     | 2024 Base Salary |     |   |           |     | % Increase |      |   |
|:---------------------|:----|:-----------------|:----|:--|----------:|:----|:-----------------|:----|:--|----------:|:----|:-----------|-----:|:--|
| Michael F. Mahoney   |     |                  |     | $